Literature DB >> 16986061

The potential for prostate cancer chemoprevention.

Otis W Brawley.   

Abstract

The dramatic international variation in prostate cancer incidence and mortality rates suggests that changeable environmental factors exert an influence. This has prompted a search for ways to prevent the disease. Epidemiologic studies suggest that dietary factors such as the carotenoid lycopene, selenium, vitamin E, and high intake of fat have roles in prostate cancer risk. Several studies show that impairment of androgen synthesis lowers the risk of prostate cancer. 5-alpha-reductase inhibitors such as finasteride have been shown to decrease prostate size by decreasing androgenic stimulation to the prostate. Other promising, but less developed, interventions include vitamin D supplements and modification of diet. Any manipulation to decrease one's relative risk of prostate cancer will by necessity have to be given to a large proportion of men who would never develop prostate cancer even without the intervention. To be acceptable, a successful preventive intervention should have few or no side effects; some additional benefits would be useful. All potential preventive interventions will need to be rigorously evaluated before they can be advocated for prostate cancer prevention.

Entities:  

Year:  2002        PMID: 16986061      PMCID: PMC1476013     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  68 in total

1.  The epidemiology of prostate cancer in Jamaica.

Authors:  F E Glover; D S Coffey; L L Douglas; M Cadogan; H Russell; T Tulloch; T D Baker; R L Wan; P C Walsh
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

2.  Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Authors:  P H Gann; J Ma; E Giovannucci; W Willett; F M Sacks; C H Hennekens; M J Stampfer
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

3.  Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group.

Authors:  J E Oesterling; J Roy; A Agha; T Shown; T Krarup; T Johansen; M Lagerkvist; G Gormley; M Bach; J Waldstreicher
Journal:  Urology       Date:  1997-07       Impact factor: 2.649

4.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer.

Authors:  K Yoshizawa; W C Willett; S J Morris; M J Stampfer; D Spiegelman; E B Rimm; E Giovannucci
Journal:  J Natl Cancer Inst       Date:  1998-08-19       Impact factor: 13.506

5.  Intake of carotenoids and retinol in relation to risk of prostate cancer.

Authors:  E Giovannucci; A Ascherio; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

Review 6.  Cancer chemoprevention.

Authors:  S M Lippman; S E Benner; W K Hong
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

7.  The role of diet in prostate cancer.

Authors:  L Kaul; M Y Heshmat; J Kovi; M A Jackson; A G Jackson; G W Jones; M Edson; J P Enterline; R G Worrell; S L Perry
Journal:  Nutr Cancer       Date:  1987       Impact factor: 2.900

8.  Dietary factors and risks for prostate cancer among blacks and whites in the United States.

Authors:  R B Hayes; R G Ziegler; G Gridley; C Swanson; R S Greenberg; G M Swanson; J B Schoenberg; D T Silverman; L M Brown; L M Pottern; J Liff; A G Schwartz; J F Fraumeni; R N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-01       Impact factor: 4.254

9.  Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study.

Authors:  M Eichholzer; H B Stähelin; K F Gey; E Lüdin; F Bernasconi
Journal:  Int J Cancer       Date:  1996-04-10       Impact factor: 7.396

10.  Free fatty acid concentrations correlated with the available fraction of estradiol in human plasma.

Authors:  P F Bruning; J M Bonfrèr
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  3 in total

1.  Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.

Authors:  Susan McCarthy; Andrea Caporali; Steve Enkemann; Maurizio Scaltriti; Steve Eschrich; Pierpaola Davalli; Arnaldo Corti; Alice Lee; Jimmy Sung; Timothy J Yeatman; Saverio Bettuzzi
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

Review 2.  Chemoprevention of prostate cancer: what can be recommended to patients?

Authors:  Janet L Colli; Christopher L Amling
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

3.  Strategies for prostate cancer prevention: Review of the literature.

Authors:  H Krishna Moorthy; P Venugopal
Journal:  Indian J Urol       Date:  2008-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.